DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Gaiane M Rauch
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- M D Anderson Cancer Center
Houston, Texas, United States
- Md Anderson in Katy
Houston, Texas, United States
- Memorial Hermann Memorial City Medical Center
Houston, Texas, United States
- Md Anderson League City
Nassau Bay, Texas, United States
- Md Anderson in Sugar Land
Sugar Land, Texas, United States
- Md Anderson in the Woodlands
The Woodlands, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Nov 2016
- Primary completion
- 30 Apr 2028
- Completion
- 30 Apr 2028
- Last update posted
- 7 Oct 2026
- Registered enrollment
- 96
- Registry id
- NCT02744053
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.